Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Oncology Research and Treatment

Vol. 40, No. 6, 2017

Issue release date: June 2017

Add all to MyReading List
Beilage
I

ONKOIMMUN 2/17

Oncol Res Treat 2017;40:I (DOI:10.1159/000478252)
MyKarger login required
Free Access
 
313

Editorial Board / Contents / Imprint

Oncol Res Treat 2017;40:313-316 (DOI:10.1159/000477476)
Free Access
Editorial
318

Head and Neck Cancer - New Insights into a Heterogeneous Disease

Klussmann J.P.
Oncol Res Treat 2017;40:318-319 (DOI:10.1159/000477255)
Free Access
Original Article
320

Risk Factors for Overall Survival Outcome in Surgically Treated Human Papillomavirus-Negative and Positive Patients with Oropharyngeal Cancer

Wuerdemann N. · Wittekindt C. · Sharma S.J. · Prigge E.-S. · Reuschenbach M. · Gattenlöhner S. · Klussmann J.P. · Wagner S.
Oncol Res Treat 2017;40:320-327 (DOI:10.1159/000477097)
Review Article
328

Epidemiology and Molecular Biology of Head and Neck Cancer

Jou A. · Hess J.
Oncol Res Treat 2017;40:328-332 (DOI:10.1159/000477127)
334

Human Papillomavirus-Related Head and Neck Cancer

Wagner S. · Sharma S.J. · Wuerdemann N. · Knuth J. · Reder H. · Wittekindt C. · Klussmann J.P.
Oncol Res Treat 2017;40:334-340 (DOI:10.1159/000477252)
Editor's Choice - Free Access
342

Novel Treatment Options in Head and Neck Cancer

Schuler P.J. · Laban S. · Doescher J. · Bullinger L. · Hoffmann T.K.
Oncol Res Treat 2017;40:342-346 (DOI:10.1159/000477254)
347

The Role of Radiotherapy in the Definitive and Postoperative Treatment of Advanced Head and Neck Cancer

Semrau R.
Oncol Res Treat 2017;40:347-352 (DOI:10.1159/000477128)
Original Article
353

Single-Center Experience with Intimal Sarcoma, an Ultra-Orphan, Commonly Fatal Mesenchymal Malignancy

Van Dievel J. · Sciot R. · Delcroix M. · Vandeweyer R.O. · Debiec-Rychter M. · Dewaele B. · Cornillie J. · Van Cann T. · Meyns B. · Schöffski P.
Oncol Res Treat 2017;40:353-359 (DOI:10.1159/000476036)
360

Malignancy in Solitary Thyroid Nodules: Evaluation of Risk Factors

Uyar O. · Cetin B. · Aksel B. · Dogan L. · Beksac K. · Akgul G.G. · Berberoglu U. · Gulcelik M.A.
Oncol Res Treat 2017;40:360-363 (DOI:10.1159/000464409)
364

Clinical Features and Treatment Outcome of Malignant Pleural Mesothelioma

Mencoboni M. · Filiberti R.A. · Taveggia P. · Grosso F. · Pasello G. · Del Corso L. · Muzio A. · Polo V. · Zucali P. · Ceresoli G.L. · Soto Parra H.J. · Auriati L. · Simonassi C.
Oncol Res Treat 2017;40:364-369 (DOI:10.1159/000464410)
370

NORAD Expression Is Associated with Adverse Prognosis in Esophageal Squamous Cell Carcinoma

Wu X. · Lim Z.-F. · Li Z. · Gu L. · Ma W. · Zhou Q. · Su H. · Wang X. · Yang X. · Zhang Z.
Oncol Res Treat 2017;40:370-374 (DOI:10.1159/000464465)
 
376

Society Bulletins

Oncol Res Treat 2017;40:376-379 (DOI:10.1159/000477111)
380

PharmaForum

Oncol Res Treat 2017;40:380-381 (DOI:10.1159/000477502)
link Artikel nur mit Kunden-Login
382

PharmaForum

Oncol Res Treat 2017;40:382-383 (DOI:10.1159/000477503)
link Artikel nur mit Kunden-Login
384

PharmaForum

Oncol Res Treat 2017;40:384-385 (DOI:10.1159/000477504)
link Artikel nur mit Kunden-Login
386

PharmaNews

Oncol Res Treat 2017;40:386-387 (DOI:10.1159/000477505)
link Artikel nur mit Kunden-Login
389

PharmaNews

Oncol Res Treat 2017;40:389 (DOI:10.1159/000475788)
link Artikel nur mit Kunden-Login
390

PharmaNews

Oncol Res Treat 2017;40:390-392 (DOI:10.1159/000477506)
link Artikel nur mit Kunden-Login
394

Meetings and Conferences

Oncol Res Treat 2017;40:394-396 (DOI:10.1159/000477110)
Free Access